Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Organisation of European Cancer Institutes |
| Country | Belgium |
| Start Date | May 01, 2023 |
| End Date | Apr 30, 2026 |
| Duration | 1,095 days |
| Number of Grantees | 55 |
| Roles | Participant; Third Party; Coordinator |
| Data Source | European Commission |
| Grant ID | 101103746 |
Cancer is the second leading cause of death in Europe with an expected increase of about 25% by 2035.
A wide and unacceptable variability in terms of access to research, innovation and quality care exists between and within countries.
Possible solutions are an increase in knowledge by funding research, and a more equitable transfer of what we already know to everyone.
Comprehensive Cancer Centers and Comprehensive Cancer Care Networks may be the core of CCIs that deliver quality care and provide resources to improve and integrate care, research and education.
Data already available confirm that the level of ""CCI maturity"" in Member States is widely different, from some countries lacking CCIs completely.
A European initiative, implemented in all Member States, based on a capacity building programme (CBP), will help reduce inequalities, in the context of other actions ongoing, such as CRANE, JANE and UNCAN. CBP is a complex intervention that requires multiple and integrated actions delivered to all the relevant stakeholders.
CBP will be designed with an inclusive approach, tailored to the baseline status, capable of creating a change and improvement in research and care, with greater integration between them, supported by an education programme. It will operate at various levels: Individuals, Institutions and Systems.
The CSA will implement the following steps: define CCI Maturity Model including quality indicators; profile the CCIs in each MS and a few ACs in terms of CCI presence and levels of maturity; design tailored CBP interventions, giving priority to MSs without any CCI; deliver online training courses open to teams in all MSs and ACs, implement targeted onsite interventions; scale up and sustain development; disseminate, exploit and report results.
The CSA will maximize impact by bridging with the work of ongoing EU cancer research projects. National focal points will be key informants in making the links between the CSA, the EC and MSs.
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie -Panstwowy Instytut Badawczy; Stichting Integraal Kankercentrum Nederland; Medizinische Universitaet Wien; Ministeru Ghas-Sahha U L-Anzjanita Attiva; Digital Institute for Cancer Outcomes Research; Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio); Institut Gustave Roussy; Hus-Yhtyma; Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca; Luxembourg Institute of Health; Organisation of European Cancer Institutes; Savmestna Onkologichna Natsionalna Mrezha; Region Syddanmark; The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin; Unicancer; Institut Catala D'Oncologia; European Organisation for Research and Treatment of Cancer Aisbl; Nacionalinis Vezio Institutas; European Cancer Organisation; Institut National Du Cancer; Sihtasutus Tartu Ulikooli Kliinikum; Oslo Universitetssykehus Hf; Deutsches Krebsforschungszentrum Heidelberg; Alleanza Contro Il Cancro; Masarykuv Onkologicky Ustav; Narodowy Instytut Zdrowia Publicznego Pzh - Panstwowy Instytut Badawczy; Geniko Antikarkiniko Ogkologiko Nosokomeio Athinon O Agios Savvas; Academisch Ziekenhuis Maastricht; Stichting Rijnstate Ziekenhuis; Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis; Institut Curie; Johann Wolfgang Goethe-Universitaet Frankfurt Am Main; European Cancer Patient Coalition; Institutia Medico-Sanitara Publica Institutul Oncologic; Onkoloski Institut Ljubljana; Karolinska Institutet; R.E Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Sciences of Ukraine; Instituto Portugues de Oncologia Do Porto Francisco Gentil, Epe; Latvijas Universitate; Deutsche Krebsgesellschaft Ev; Scuola Europea Di Oncologia Associazione; Fondazione Policlinico Universitario Agostino Gemelli Irccs; Region Stockholm; Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna Institucia; Centre International de Recherche Sur Le Cancer; Orszagos Onkologiai Intezet; Fondazione Irccs Istituto Nazionale Dei Tumori; Fondazione Del Piemonte Per L'Oncologia; G.O.C.German Oncology Center Limited; Region Skane; Klinicki Bolnicki Centar Sestre Milosrdnice Ustanova; Sciensano; Technische Universitaet Dresden; Association Hospitaliere de Bruxelles-Centre Hospitalier Universitaire Jules Bordet; Istituti Fisioterapici Ospitalieri
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant